Table 3 Comparison between scores obtained with the Motola’s rating system and the Ahlqvist-Rastad’s rating system
From: Assessment of the therapeutic value of new medicines marketed in Australia
Ahlqvist-Rastad’s rating system | |||||
|---|---|---|---|---|---|
Motola’s rating system | Added therapeutic value | Similar therapeutic value | Inferior therapeutic value | Uncertain therapeutic value | Total |
Important | 7 (36.8%) | - | - | - | 7 |
Moderate | 9 (47.4%) | 3 (12.0%) * | - | 5 (50.0%) ** | 17 |
Modest | 3 (15.8%) | - | - | 1 (10.0%) *** | 4 |
Pharmacological | - | 2 (8.0%) | 2 (40.0%) | 2 (20.0%) | 6 |
Technological | - | 20 (80.0%) | 3 (60.0%) | 2 (20.0%) | 25 |
TOTAL | 19 | 25 | 5 | 10 | 59 |